1. Home
  2. ACDC vs EVO Comparison

ACDC vs EVO Comparison

Compare ACDC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProFrac Holding Corp.

ACDC

ProFrac Holding Corp.

HOLD

Current Price

$6.46

Market Cap

971.3M

Sector

Energy

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.42

Market Cap

821.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACDC
EVO
Founded
2014
1993
Country
United States
Germany
Employees
N/A
4766
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
971.3M
821.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ACDC
EVO
Price
$6.46
$2.42
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$5.83
$7.00
AVG Volume (30 Days)
1.4M
108.5K
Earning Date
03-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,941,800,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.37
$7.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.08
$2.31
52 Week High
$10.70
$4.80

Technical Indicators

Market Signals
Indicator
ACDC
EVO
Relative Strength Index (RSI) 59.77 28.78
Support Level $3.48 $2.31
Resistance Level $7.47 $3.78
Average True Range (ATR) 0.49 0.09
MACD 0.08 -0.04
Stochastic Oscillator 56.05 9.98

Price Performance

Historical Comparison
ACDC
EVO

About ACDC ProFrac Holding Corp.

ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. The company operates in three segments: Stimulation Services, Proppant Production, and Manufacturing. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: